Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127362331 | 12736233 | 1 | I | 20160906 | 20160912 | 20160912 | EXP | FR-JNJFOC-20160908258 | JANSSEN | THIERY-VUILLEMIN A, CUSSAC AL, CHAIGNEAU L, VILLANUEVA C, BAZAN F, MONTCUQUET P, ET AL. SEQUENTIAL TAXANE AND ANTHRACYCLINE-CONTAINING NEOADJUVANT REGIMENS: THE SEQUENTIAL ORDER IMPACT. THE BREAST 2011;20:46-49. | 0.00 | Y | 0.00000 | 20160912 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127362331 | 12736233 | 1 | PS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | U | U | 50718 | 60 | MG/M**2 | LIPOSOME INJECTION | ||||||
| 127362331 | 12736233 | 2 | SS | EPIRUBICIN | EPIRUBICIN | 1 | Unknown | U | 0 | 100 | MG/M**2 | UNSPECIFIED | |||||||
| 127362331 | 12736233 | 3 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | U | 0 | 500 | MG/M**2 | UNSPECIFIED | |||||||
| 127362331 | 12736233 | 4 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | Unknown | U | 0 | 500 | MG/M**2 | UNSPECIFIED | |||||||
| 127362331 | 12736233 | 5 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | U | 0 | 100 | MG/M**2 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127362331 | 12736233 | 1 | Breast cancer |
| 127362331 | 12736233 | 2 | Breast cancer |
| 127362331 | 12736233 | 3 | Breast cancer |
| 127362331 | 12736233 | 4 | Breast cancer |
| 127362331 | 12736233 | 5 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127362331 | 12736233 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127362331 | 12736233 | Alopecia | |
| 127362331 | 12736233 | Anaemia | |
| 127362331 | 12736233 | Diarrhoea | |
| 127362331 | 12736233 | Febrile neutropenia | |
| 127362331 | 12736233 | Lymphoedema | |
| 127362331 | 12736233 | Mucosal inflammation | |
| 127362331 | 12736233 | Neurotoxicity | |
| 127362331 | 12736233 | Neutropenia | |
| 127362331 | 12736233 | Skin toxicity | |
| 127362331 | 12736233 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |